Healthcare Business Review Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Healthcare Business Review
Neurotechnology devices are gaining ground with massive advancements in signal quality, biofeedback, and hardware to obtain better insights into the nervous system and activities of the brain. Startups and established neurotech companies are fueling innovation to develop neurotechnology devices that deliver better outcomes and personalised therapies.
These cutting-edge developments are driving the growth of the neurotech market, which is estimated to reach $21.9 billion by 2026 at a CAGR of 15.3 percent during the forecast period.
Recent market analysis reports identify the market growth is due to the rising incidence of neurological diseases such as brain tumors, epilepsy, Alzheimer’s, multiple sclerosis, and Parkinson’s in patients and the indispensable need to diagnose, prevent, and treat them. Neurostimulation among the various segments of neurotech is a predominant factor boosting the market growth from the adoption of deep brain stimulation to treat patients suffering from epilepsy, dystonia, tremors and Parkinson’s disease.
To bring the spotlight on the vital developments in the neurotech industry, Healthcare Business Review illustrates how neurotechnology companies are enhancing their operations and meeting business goals by leveraging cutting-edge neuroscience technologies. The edition features thought leadership articles from Michael King, Chief Medical Officer at Upperline Health, who sheds light on non-invasive methods for managing peripheral neuropathy. It also includes insights from David Baker, Chief Information and Digital Officer at Pacific Dental Services, who talks about transforming systemic health by implementing EHR in dentistry.
The edition also presents some of the top neurotech companies that deliver the best outcomes for their clients, notably BrainTap Technologies, an advanced wellness and fitness company boosting brain fitness and transforming the lives of many through its advanced neuro algorithm.
We hope you find the right neurotechnology company to assist you with the industry-best diagnosis and treatment options to significantly improve and rehabilitate patients’ brain health.
Let us know your thoughts!
Usually, the qualified subscribers of our magazine nominate companies with whom they have collaborated and experienced exceptional results to be in this list. Did a company you recently worked with give you stellar results and ROI? Did it turn out to be one you would wholeheartedly recommend to peers? Or do you know of such an outstanding company through your network? Please fill in the details below and nominate them to be featured here.
BrainTap Technologies, a brain wellness tech company established with a singular mission in mind: to better a billion brains. BrainTap’s innovative technologies produce brainwave entrainment—the harmonization of brainwaves to a specialized sound—providing users the same relaxation response as meditation to balance and reverse the effect of stress on the body.
At Flow Neuroscience, the company develops a new kind of depression treatment that combines an easy-to-use brain stimulation headset with an engaging, personalized mobile app to target both the physical and behavioural elements of major depressive disorder (MDD)
g.tec medical engineering GmbH manufactures biosignal amplifiers, data acquisition systems, real-time processing systems, and EEG processing software. g.tec has an in-house design team for hardware and software components. The systems are used for neuroscience research with non-invasive and invasive sensors and to develop brain-computer interfaces. g.tec uses BCI technology for the assessment, rehabilitation or mapping of brain functions
g.tec medical engineering GmbH
Management
Dr. Christoph Guger and Dr. Günter Edlinger Founders
Halo Neuroscience is a neurotechnology company focused on human performance. Their first product, Halo Sport, utilizes neuropriming technology to accelerate the neurologic gains of strength and skill learning that result from athletic training
Neosoma is a neuro-oncology AI platform providing AI imaging solutions for precise medical management. The company also builds clinician-first, A.I. deep-learning neurodiagnostic solutions for neuroradiologists, radiation oncologists, neurologists, neurosurgeons, and neuroscience researchers. Their technology integrates seamlessly between healthcare professionals and allows the integration of non-imaging information for more precise analysis of patient’s data.
NeuroNexus is a global leader in innovative neural interface products and technologies to meet current and upcoming neuroscience research, neurosurgery, and neuromodulation needs.NeuroNexus powers neuroscience research through innovative neural probes, systems, and data analytics software. NeuroNexus probes include a full line of high-quality, customizable microelectrode arrays for electrophysiology and optogenetics research
Neurotech is a proven leader in delivering greater test accuracy as well as a consistently positive patient experience, with a 95% patient satisfaction rating. The firm provides all types of Electroencephalogram (EEG) studies to a wide variety of patients. Neurotech is the physician-trusted partner for reliable and accurate in-home setups with around-the-clock remote monitoring
Neurotech
Management
Keith Morgan, R. EEG T., MBA, Founder and Chief Executive Officer
Optios is a leader in the rapidly emerging Neuroperformance industry. Optios uses proprietary, state-of-the-art neurotechnology to unlock the brain’s potential and optimize performance
Penumbra, Inc. is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures, and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet needs. Penumbra supports healthcare providers, hospitals, and clinics in more than 100 countries
Rune Labs is a software and data platform for neuromodulation and brain therapies of the future. The platform's software-as-a-service platform works with existing and emerging neuromodulation systems to manage complex therapies and get the most value out of available data
